Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro

Journal of Leukocyte Biology

Volumn 93, Issue 5, 2013, Pages 811-818

  Siewe, Basile ^a   Stapleton, Jack T ^c   Martinson, Jeffrey ^a   Keshavarzian, Ali ^a   Kazmi, Nazia ^a   Demarais, Patricia M ^a,d   French, Audrey L ^a,d   Landay, Alan ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF IOWA   (United States)

^d Jr Hospital of Cook County   (United States)

Author keywords

IL 10; Immune activation; Immune exhaustion

Indexed keywords

CD40 LIGAND; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INTERLEUKIN 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD274; B-LYMPHOCYTES, REGULATORY; BIOLOGICAL MARKERS; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MIDDLE AGED; TOLL-LIKE RECEPTORS; VIRAL LOAD;

EID: 84877058009     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0912436     Document Type: Article

References (31)

1. Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D., Ahmed, R. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213.
2. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klenerman, P., Ahmed, R., Freeman, G. J., Walker, B. D. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354.
3. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R., Delwart, E., Sepulveda, H., Balderas, R. S., Routy, J. P., Haddad, E. K., Sekaly, R. P. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198-1202.
4. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., Oldstone, M. B. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301-1309.
5. Said, E. A., Dupuy, F. P., Trautmann, L., Zhang, Y., Shi, Y., El-Far, M., Hill, B. J., Noto, A., Ancuta, P., Peretz, Y., Fonseca, S. G., Van Grevenynghe, J., Boulassel, M. R., Bruneau, J., Shoukry, N. H., Routy, J. P., Douek, D. C., Haddad, E. K., Sekaly, R. P. (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16, 452-459.
6. Brockman, M. A., Kwon, D. S., Tighe, D. P., Pavlik, D. F., Rosato, P. C., Sela, J., Porichis, F., Le Gall, S., Waring, M. T., Moss, K., Jessen, H., Pereyra, F., Kavanagh, D. G., Walker, B. D., Kaufmann, D. E. (2009) IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114, 346-356.
7. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., Anderton, S. M. (2002) B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950.
8. Mauri, C., Bosma, A. (2012) Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221-241.
9. Bouaziz, J. D., Le Buanec, H., Saussine, A., Bensussan, A., Bagot, M. (2012) IL-10 producing regulatory B cells in mice and humans: state of the art. Curr. Mol. Med. 12, 519-527.
10. Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A., Blair, P., Dusheiko, G., Gill, U., Kennedy, P. T., Brunetto, M., Lampertico, P., Mauri, C., Maini, M. K. (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J. Immunol. 189, 3925-3935.
11. Inoue, S., Leitner, W. W., Golding, B., Scott, D. (2006) Inhibitory effects of B cells on antitumor immunity. Cancer Res. 66, 7741-7747.
12. Horikawa, M., Minard-Colin, V., Matsushita, T., Tedder, T. F. (2011) Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J. Clin. Invest. 121, 4268-4280.
13. Blair, P. A., Norena, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., Mauri, C. (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32, 129-140.
14. Mauri, C., Gray, D., Mushtaq, N., Londei, M. (2003) Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489-501.
15. Dilillo, D. J., Weinberg, J. B., Yoshizaki, A., Horikawa, M., Bryant, J. M., Iwata, Y., Matsushita, T., Matta, K. M., Chen, Y., Venturi, G. M., Russo, G., Gockerman, J. P., Moore, J. O., Diehl, L. F., Volkheimer, A. D., Friedman, D. R., Lanasa, M. C., Hall, R. P., Tedder, T. F. (2013) Chronic lymphocytic leukemia and regulatory B cells share IL-10-competence and immunosuppressive function. Leukemia 27, 170-182.
16. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371.
17. Imbeault, M., Ouellet, M., Giguere, K., Bertin, J., Bélanger, D., Martin, G., Tremblay, M. J. (2011) Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J. Virol. 85, 2189-2200.
18. Zloza, A., Schenkel, J. M., Tenorio, A. R., Martinson, J. A., Jeziorczak, P. M., Al-Harthi, L. (2009) Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface. Blood 114, 3841-3853.
19. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., Ho, D. D. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655.
20. Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K., Osterhaus, A. D., Schuitemaker, H., Miedema, F. (1995) Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181, 1365-1372.
21. Yang, O. O., Kalams, S. A., Trocha, A., Cao, H., Luster, A., Johnson, R. P., Walker, B. D. (1997) Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71, 3120-3128.
22. Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H. C., Zhang, H., Margolick, J. B., Blankson, J. N., Siliciano, R. F. (2012) Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36, 491-501.
23. Shete, A., Thakar, M., Singh, D. P., Gangakhedkar, R., Gaikwad, A., Pawar, J., Paranjape, R. (2012) Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations. AIDS Res. Hum. Retroviruses 28, 835-843.
24. Trautmann, L., Said, E. A., Halwani, R., Janbazian, L., Chomont, N., El-Far, M., Breton, G., Haddad, E. K., Sekaly, R. P. (2007) Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections. Curr. Opin. HIV AIDS 2, 219-227.
25. Liu, Z., Cumberland, W. G., Hultin, L. E., Prince, H. E., Detels, R., Giorgi, J. V. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol 16, 83-92.
26. Velupillai, P., Garcea, R. L., Benjamin, T. L. (2006) Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and-resistant mice. J. Immunol. 176, 1148-1153.
27. Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., Hall, R. P., St Clair, E. W., Tedder, T. F. (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530-541.
28. Matano, T., Shibata, R., Siemon, C., Connors, M., Lane, H. C., Martin, M. A. (1998) Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72, 164-169.
29. Kuroda, M. J., Schmitz, J. E., Seth, A., Veazey, R. S., Nickerson, C. E., Lifton, M. A., Dailey, P. J., Forman, M. A., Racz, P., Tenner-Racz, K., Letvin, N. L. (2000) Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. Blood 96, 1474-1479.
30. Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., Kostrikis, L. G., Zhang, L., Perelson, A. S., Ho, D. D. (1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991-998.
31. Benito, J. M., Lopez, M., Lozano, S., Martinez, P., Gonzalez-Lahoz, J., Soriano, V. (2004) CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res. Hum. Retroviruses 20, 227-233.